Zogenix (NASDAQ: ZGNX) reported Q2 EPS of ($0.89), $0.11 worse than the analyst estimate of ($0.78). Revenue for the quarter ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE